Virtual Library

Start Your Search

Mst Shamima Akter

Author of

  • +

    Lunch & Poster Display session (ID 58)

    • Event: ELCC 2019
    • Type: Poster Display session
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
    • +

      53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries (ID 586)

      12:30 - 13:00  |  Presenting Author(s): Mst Shamima Akter

      • Abstract
      • Slides


      Bangladesh is ranked 6th among the Tuberculosis high burden countries. Sometimes, pulmonary tuberculosis (PTB) mimics the early symptoms of lung cancer. Developing countries like Bangladesh, with limited diagnostic facilities, often misdiagnose early lung cancer as smear negative PTB. According to national guidelines for PTB, smear negative PTB is defined as the cases diagnosed on the basis of X-ray abnormalities or suggestive histology and extra pulmonary cases without laboratory confirmation. This observational study has been done to find out the ratio of misdiagnosis of lung cancer as Smear Negative PTB.

      a9ded1e5ce5d75814730bb4caaf49419 Methods

      This observational study was done between June, 2017 to January, 2018 at OPD of NIDCH (National Institute of Diseases the Chest & Hospital), Dhaka, Bangladesh. Inclusion criteria for the confirmation of PTB were: symptoms not improving after 3 weeks of anti-TB treatment; non-improving chest X-ray; new symptoms; no prior anti-TB treatment; smear negative PTB. For confirmation of AFB (Acid fast bacillus) smear test, CT scan of chest, GeneXpert of sputum, Mycobacterium culture and histological confirmation were performed. During this period, 172 cases were included in the study. After confirmation of the diagnosis, every case was treated according to national TB guidelines and refered to other tertiary specialized hospitals. After changing of the treatment protocol, 3-weekly follow up was done for 2 months with chest X-ray and other blood parameters.

      20c51b5f4e9aeb5334c90ff072e6f928 Results

      The investigations mentioned above were performed in all cases included in the study: 35 cases (20.34%) were diagnosed as lung cancer by histological confirmation. 81 cases were (47.09%) diagnosed as multidrug-resistant TB and 2 cases (1.16%) were diagnosed as extensively drug-resistant TB. Other cases (31.39%) were confirmed as PTB.

      fd69c5cf902969e6fb71d043085ddee6 Conclusions

      In countries with a high tuberculosis burden and lack of facilities for guided biopsy or fine needle aspiration, except in tertiary hospitals, plays an important role in delay of early diagnosis of lung cancer. In addition, flexible national guidelines and DOT (direct observed therapy) of anti-TB drugs are given at no cost to patients are also contributory factors. In this short observational study, it was found that a number of patients received anti-TB drug based on clinical diagnosis has been diagnosed as Lung cancer that were previously diagnosed as Smear negative PTB on clinical ground and Chest X-ray. This finding suggests that national policy makers should consider that patients with smear negative PTB (clinical diagnosed PTB) need close follow up and proper referral to specialized & tertiary hospitals where there are facilities for confirming the diagnosis. To make and change in national guideline this observational study should be run in multi center in the country.

      b651e8a99c4375feb982b7c2cad376e9 Legal entity responsible for the study


      213f68309caaa4ccc14d5f99789640ad Funding

      Has not received any funding.

      682889d0a1d3b50267a69346a750433d Disclosure

      All authors have declared no conflicts of interest.


      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.